Language:
Social networks:
Work schedule:
Address:
Call:

OncoRisk Complete test

OncoRisk Complete is the most extensive, comprehensive oncogenetics panel that covers the analysis of 88 genes to determine the hereditary risks of the most common cancers based on the patient's DNA analysis.

The OncoRisk Complete test examines genetic mutations that can increase the likelihood of developing cancer and provides information about individual risks.

Who can use the OncoRisk Complete test?

  • First of all, patients who are planning to become parents should pay special attention to the OncoRisk Complete test, as the service will allow them to assess the potential risks of developing cancer in future parents and thus make informed decisions about family planning.
  • The test is especially recommended for couples planning IVF treatment. OncoRisk Complete makes it possible to avoid unpredictable genetic consequences and take advantage of the possibility of preimplantation genetic diagnosis of embryos if one of the future parents has a mutation in a gene that is associated with the possibility of developing cancer.
  • Patients who have an increased risk of cancer (for example, relatives with a history of breast, ovarian, colon, or other types of cancer);
  • Patients with an increased need for cancer prevention, as well as families with hereditary cancer.
Order a call

Advantages of the procedure

The OncoRisk Complete test will provide accurate and detailed information about the susceptibility to various types of cancer, which will allow early detection of the disease and recommend personalized tests for patients who need treatment with assisted reproductive technologies.

If mutations in genes are detected by the OncoRisk Complete test, a geneticist at IVMED will help you find out important information during a personal consultation at your request.

OncoRisk Complete is an important mechanism for:

  • early detection of potential risks of developing cancer,
  • providing personalized recommendations to reduce the likelihood of developing cancer,
  • identifying which mutation is present and in which gene, for further effective planning of preventive measures,
  • obtaining recommendations for personalized research in the treatment of patients with reproductive problems.

For the OncoRisk Complete extended panel of hereditary cancers (88 genes), the material is venous blood or buccal epithelium.

The term for this analysis is 20 working days from the date of receipt of the samples for testing by the laboratory.

Hereditary forms of cancer account for a significant percentage of all cancer cases.

These types of cancer are clearly associated with the inheritance of a gene with a "breakdown" - a pathogenic mutation. Altered genes with mutations are passed down from generation to generation and significantly increase the risk of developing diseases. Each patient carrying a hereditary oncogenic mutation has a several (and sometimes hundreds) times higher chance of contracting a specific cancer.

It is well known that a person inherits 50% of the genes in the germ cells (gametes) from the father and 50% from the mother, meaning that a damaged gene with mutations can be inherited from either parent. The probability of inheriting such a gene is 50%. The same probability of inheriting a mutation exists in the brothers and sisters of a patient who carries mutations in genes. For more distant relatives, the possibility of inheriting mutations decreases in proportion to the degree of kinship.

The following markers indicate a possible hereditary mutation:

  • family accumulation and hereditary transmission of the disease;
  • early age of onset of the disease;
  • bilateral or multifocal lesions;
  • specific tumor associations;
  • several forms of cancer in the patient or one of his relatives;
  • the presence of a pathogenic hereditary mutation in a close relative.

If you have a history of cancer in your family, you should find out if you and your family are at risk of developing hereditary forms of cancer.

 

Sign up for a consultation

Leave your contact information and our consultant will call you back and select the most convenient time, date, and doctor for a visit to the reproductive center or online consultation.

By clicking, you accept the terms and conditions "Consent to the collection and processing of personal data"
Test to determine sperm viability
OncoRisk Complete test
Research of ethnic origin (genealogical analysis)
Determination of ploidy of testicular biopsy cells
Vasectomy
ENDOMETRIO
ICSI
Micro TESE

Specialists of this service

Strelko
Galina Strelko
medical director, obstetrician-gynecologist of the highest category, Doctor of Medical Sciences
Work experience: more than 25 years
ulanova
Veranika Ulanova
Head of the medical and diagnostic department, obstetrician-gynecologist of the highest category
Work experience: more than 21 years
parpalej-1-1-min
Karolina Parpaley

obstetrician-gynecologist of the first category

Work experience: more than 16 years
макаренко
Liliia Makarenko

obstetrician-gynecologist of the highest category

Work experience: more than 14 years
пранова
Olga Pranova

obstetrician-gynecologist of the highest category

Work experience: more than 26 years
магера
Yulia Magera
obstetrician-gynecologist
Work experience: more than 6 years

Make an appointment

Leave your contact details and we will get back to you soon!

Make an appointment

Leave your contact details and we will get back to you soon!